Zevra Therapeutics
ZVRA
ZVRA
148 hedge funds and large institutions have $385M invested in Zevra Therapeutics in 2026 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 53 increasing their positions, 53 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% less funds holding
Funds holding: 158 → 148 (-10)
27% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 26
32% less call options, than puts
Call options by funds: $14.2M | Put options by funds: $20.7M
Holders
148
Holding in Top 10
2
Calls
$14.2M
Puts
$20.7M
Top Buyers
| 1 | +$10.8M | |
| 2 | +$10.4M | |
| 3 | +$7.38M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$6.76M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$4.38M |
Top Sellers
| 1 | -$4.9M | |
| 2 | -$3.09M | |
| 3 | -$2.57M | |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$2.24M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$2.07M |
